Diagnosis of upper limb lymphedema: development of an evidence-based approach

• Published in: Acta oncologica 2016-12, Vol.55 (12), p.1477-1483
• Main Authors: Dylke, E S, Schembri, G P, Bailey, D L, Bailey, E, Ward, L C, Refshauge, K, Beith, J, Black, D, Kilbreath, S L
• Format: Article
• Language: English
• Subjects: Breast Neoplasms - complications; Breast Neoplasms - therapy; Case-Control Studies; Combined Modality Therapy - adverse effects; Evidence-Based Medicine; Female; Follow-Up Studies; Humans; Lymphedema - diagnosis; Lymphedema - etiology; Middle Aged; Neoplasm Staging; Prognosis; Upper Extremity - pathology
• ISSN: 0284-186X; 1651-226X
• DOI: 10.1080/0284186X.2016.1191668

The diagnosis of secondary upper limb lymphedema (LE) is complicated by the lack of an agreed-upon measurement tool and diagnostic threshold. The aim of this study was to determine which of the many commonly used and normatively determined clinical diagnostic thresholds has the best diagnostic accuracy of secondary upper limb LE, when compared to diagnosis by an appropriate reference standard, lymphoscintigraphy. The arms of women treated for breast cancer with and without a previous diagnosis of LE, as well as healthy controls, were assessed using lymphoscintigraphy, bioimpedance spectroscopy (BIS) and perometry. Dermal backflow score determined from lymphoscintigraphy imaging assessment (reference standard) was compared with diagnosis by both commonly used and normatively determined diagnostic thresholds for volume and circumference measurements as well as BIS. For those with established dermal backflow, all commonly used and normatively determined diagnostic thresholds accurately identified presence of LE compared with lymphoscintigraphy diagnosis. In participants with mild to moderate changes in dermal backflow, only a normatively determined diagnostic threshold, set at two standard deviations above the norm, for arm circumference and full arm BIS were found to have both high sensitivity (81% and 76%, respectively) and specificity (96% and 93%, respectively). For this group, strong, and clinically useful, positive (23 and 10, respectively) and negative likelihood (0.2 and 0.3) ratios were found for both the circumference and bioimpedance diagnostic thresholds. For the first time, evidence-based clinical diagnostic thresholds have been established for secondary LE. With mild LE, normatively determined circumference and BIS thresholds are superior to the commonly used thresholds.